Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

More potent and selective PDE5 inhibitors developed

Aug. 29, 2000

MCA lifts clinical hold on Vasomax

Aug. 21, 2000

New compounds interacting with muscarinic M3 receptor useful for urinary disorders

Aug. 18, 2000

New series of tricyclic vasopressin agonists under study at AHP

Aug. 17, 2000

U.K. clinical hold on Invicorp removed

Aug. 16, 2000

New selective alpha1A receptor antagonists useful for treatment of BPH

Aug. 10, 2000

Novel arylpiperazines assessed as uroselective agents for BPH

Aug. 8, 2000

Gene variant associated with less risk of renal impairment following heart surgery

Aug. 4, 2000

Trial in healthy subjects confirms safety and pharmacological effects of TF-505

July 28, 2000

Acetylcysteine useful in preventing contrast agent-induced reductions in renal function

July 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...